Fidji Simo

OpenAI has undergone significant leadership changes, with multiple senior executives departing in 2026. Notable exits include chief revenue officer Denise Dresser, Brad Lightcap, and applications CEO Fidji Simo. The departures followed a year of turnover, with reasons cited including pursuing new ventures or dealing with health issues.

Fidji Simo, a French-born businesswoman and former CEO of Instacart and top executive at OpenAI, has begun working on curing chronic diseases, including her own condition, POTS. Her new startup, ChronicleBio, aims to use AI to analyze blood samples. This analysis will help segment POTS patients into more granular cohorts, thereby making clinical drug trials more targeted and successful.

Multiple high-profile tech executives, including Lilian Weng, Fidji Simo, Greg Yang, and Tom Siebel, have resigned citing health issues linked to intense work demands. The article highlights growing concerns about burnout in the AI industry, where relentless productivity expectations and automation are straining human workers.

AI industry leaders Lilian Weng, Fidji Simo, and Greg Yang have stepped down from full-time roles due to stress and health issues linked to the intense pace of the AI race. The article highlights rising concerns about burnout and chronic illnesses among AI professionals, despite the industry's relentless competition for market dominance.

AI startup founders are experiencing severe stress and health issues due to the intense competition and demands of the AI industry. Leaders like Lilian Weng of Thinking Machines Lab, OpenAI's Fidji Simo, and xAI cofounder Greg Yang have stepped back or reduced roles for health reasons. Financial pressures, 996 work schedules, and talent wars exacerbate burnout among tech leaders.

Lilian Weng, cofounder of Thinking Machines Lab, steps down citing stress and illness related to startup demands. Her departure follows similar health-related exits by AI industry leaders Fidji Simo and Greg Yang.

Fidji Simo left OpenAI due to a chronic medical issue, leading to Greg Brockman's clearer role as power consolidates under him ahead of a potential IPO.

Fidji Simo, applications CEO at OpenAI, is stepping down from her full-time role to become a part-time advisor due to postural tachycardia syndrome (POTS), a chronic illness she has managed since 2019. Simo took medical leave in April after a severe exacerbation of her condition, which causes symptoms like heart palpitations and fainting.

Fidji Simo, the number 2 executive at OpenAI, has stepped down from her full-time role for health reasons and will transition to a part-time advisory role. She announced the decision in a post on X, formerly Twitter.

Fidji Simo, an OpenAI executive, stepped down from her full-time role due to a chronic illness called POTS. She revealed that Mark Zuckerberg had advised her to take a year off years earlier, but she declined. Simo now regrets not heeding his advice and will transition to a part-time advisory role at OpenAI.

Fidji Simo, OpenAI's product chief and Sam Altman's second in command, is stepping down and becoming a part-time advisor due to her worsening POTS condition.

Fidji Simo is stepping down as OpenAI's head of product and business due to a worsening chronic illness. She went on medical leave in April, and OpenAI President Greg Brockman assumed her responsibilities during her absence. Simo will remain at OpenAI as a part-time advisor.

Fidji Simo is stepping down from OpenAI due to a chronic illness and will transition to an advisor role. She took medical leave in April to focus on recovery.

Fidji Simo, OpenAI's No. 2 executive, is stepping down from her full-time role due to an extended medical leave. Her departure creates a leadership vacuum as OpenAI considers an IPO and competes with Anthropic in the enterprise market.

Fidji Simo is leaving her full-time role as OpenAI's AGI chief and transitioning to a part-time advisor due to a neuroimmune condition. Around the same time, COO Brad Lightcap and CMO Kate Rouch also stepped down, with Rouch citing health reasons and planning to return to a more narrowly scoped role.

Fidji Simo is stepping down from her role as CEO of applications at OpenAI after medical leave due to a chronic illness. She will transition to a part-time advisor role while focusing on her recovery.

Fidji Simo, OpenAI’s CEO of AGI Deployment, is stepping down after taking significant medical leave. She will remain with the organization as a part-time adviser.

OpenAI is reorganizing its structure to focus on AI agents, with Greg Brockman leading product development. The company aims to create a unified AI agent platform by merging ChatGPT and Codex. This change follows recent leadership adjustments, including AGI boss Fidji Simo's medical leave.